Maternity

The Rise of Empowered Parenting: Social Media Sparks a Revolution of Embracing Imperfection and Authenticity Among Parents

Retrieved on: 
Monday, March 25, 2024
Family, Data Management, Data Analytics, Technology, Consumer, Teens, Parenting, Children, Baby, Maternity, Other Communications, Publishing, Communications, Social Media, Other Professional Services, Consulting, Media, Professional Services, Other Consumer, Women, Other Technology, Men, Internet, Pew, Mother, Bump, Climate change, Generation, Marriage, Face, Motivation, Learning, Environment, Parent, Partnership, Bias, Yoga, Shame, Social media, Child, Politics, Great Recession, Father, Pregnancy, Judgement, Humour, Carbon, Hobby, Marketing, Woman, Male, American Dream, Empowerment, Pew Research Center, Generation Alpha, Supreme court, Content, Global recession, Intelligence quotient, Traction, Creativity, Disability, Workforce, Habit, Society, Report, Toy

As the antidote to feeling shame and judgment resulting in high levels of stress, today’s parents are prioritizing authenticity, humor and personal well-being on their parenting journeys.

Key Points: 
  • As the antidote to feeling shame and judgment resulting in high levels of stress, today’s parents are prioritizing authenticity, humor and personal well-being on their parenting journeys.
  • They are forsaking unrealistic standards for showcasing raw, relatable moments, whether in person or on social networks.
  • Social media has contributed to this new, empowered approach to embracing imperfections.
  • According to a recent Pew Research study, 65% of parents rarely or never feel judged by their community of parents.

Hasbro Announces Changes to Board of Directors

Retrieved on: 
Monday, March 25, 2024
Professional Services, Family, General Entertainment, Consumer, Other Retail, Entertainment, Other Manufacturing, Toys, Business, Manufacturing, Retail, Other Professional Services, Parenting, Children, Other Entertainment, Online Retail, Baby, Maternity, Nexon, Emeritus, Primrose Schools, Growth, Zynga Poker, Darkness, Take-Two Interactive, IWG, DNA, Electronic Arts, Magic, Puzzle, CSR Racing, Investment, Retirement, Friends, IWG plc, Captain, Annual general meeting, Corporation, Management

“We are thrilled to have Frank, Darin, and Owen join our accomplished and diverse Board of Directors,” said Rich Stoddart, Chair of Hasbro’s Board of Directors.

Key Points: 
  • “We are thrilled to have Frank, Darin, and Owen join our accomplished and diverse Board of Directors,” said Rich Stoddart, Chair of Hasbro’s Board of Directors.
  • Each of them will add tremendous value and unique perspective to our Board.
  • Alan will continue to be actively engaged with Hasbro helping to guide the company’s charitable efforts, in addition to his many other philanthropic pursuits.
  • That won’t change and I’m excited to support Hasbro in my next chapter.”

China In-Vitro Fertilization Market Research Report 2023-2030 Featuring Vitrolife, Cloudnine, Nova IVI Fertility, Monash, Maria Fertility Hospital, Bangkok Fertility Center, and EMD Serono - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
General Health, Other Health, Consumer, Health, Baby, Maternity, Consciousness, Infertility, Prevalence, IVF, Sterilization, Fertility, Fertilisation, Woman, Male, Infection, Patient safety, ICSI, Birth control

Economic improvement has fueled a terrific increase in the China in-vitro Fertilization (IVF) market.

Key Points: 
  • Economic improvement has fueled a terrific increase in the China in-vitro Fertilization (IVF) market.
  • Disposable devices are predicted to be among the instruments used considerably in the China In-Vitro Fertilization (IVF) market.
  • ICSI IVF is foreseen to be among the considerably utilized processes in the China In-Vitro Fertilization (IVF) market.
  • Fertility clinics are projected to experience a considerable increase in utilization in the China In-Vitro Fertilization (IVF) market.

United States In-Vitro Diagnostics Market Analysis 2023-2030: Technological Advancements Drive IVD Adoption, Enhancing Patient Outcomes Fueling Demand - ResearchAndMarkets.com

Retrieved on: 
Friday, March 22, 2024
Biotechnology, Baby, Maternity, Health, General Health, Health Technology, Medical Devices, Research, Hospitals, Genetics, Consumer, Science, Automation, PCR, Cardiovascular disease, Hematology, Haemophilia, Diabetes, Ageing, American Cancer Society, Tissue, Cancer, IVD, Leukemia, Workflow, Anemia, Blood, Medical device

The market is poised for growth with the development of automatic IVD structures that provide improved efficiency, accuracy, and throughput.

Key Points: 
  • The market is poised for growth with the development of automatic IVD structures that provide improved efficiency, accuracy, and throughput.
  • This reflects a commitment to enhancing patient care through innovative technology and positioning the United States at the forefront of the in-vitro diagnostics market.
  • Technological advancements are set to propel the United States in the in vitro diagnostics (IVD) market.
  • Instruments are predicted to be among the leading products in the United States in vitro diagnostics (IVD) market.

Smart/Artificial Intelligence for In-Vitro Diagnostics Market Research Report 2024 - ResearchAndMarkets.com

Retrieved on: 
Thursday, March 21, 2024
General Health, Oncology, Consumer, Technology, Medical Devices, Hospitals, Genetics, Artificial Intelligence, Health Technology, Baby, Maternity, Biotechnology, Practice Management, Health, Diagnosis, Genomics, Growth, Infection, Medication, Science, Application, Intelligence, Consultant, Artificial intelligence, Research, Hospital, AI, Laboratory, Radiology, Physician, Medicine, Medical device

The "Smart In-Vitro Diagnostics - Artificial Intelligence for In Vitro Diagnostics Markets by Application, by Technology and by User with Executive and Consultant Guides 2023-2027" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Smart In-Vitro Diagnostics - Artificial Intelligence for In Vitro Diagnostics Markets by Application, by Technology and by User with Executive and Consultant Guides 2023-2027" report has been added to ResearchAndMarkets.com's offering.
  • The market is exploding as physicians use all the information they can get to battle disease.
  • Broad-spectrum blood testing and artificial intelligence will routinely provide medical diagnosis in the near future according to a this new report.
  • The report explores recent developments in artificial intelligence, genomics, and costs that affect the market outlook.

Pediatric Cancer Research Foundation Expands Executive Leadership Team

Retrieved on: 
Wednesday, March 20, 2024
Research, Philanthropy, Oncology, Consumer, Fund Raising, Teens, Foundation, Science, Children, Baby, Maternity, Other Philanthropy, Health, Other Science, American Heart Association, Growth, PCRF, City, Cancer, Marketing, Management

The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, today announced the expansion of its leadership team.

Key Points: 
  • The Pediatric Cancer Research Foundation (PCRF), a nonprofit focused on transforming pediatric cancer care by funding research breakthroughs, today announced the expansion of its leadership team.
  • The Foundation has granted $46 million to leading researchers in pediatric cancer and aims to increase that amount substantially in coming years.
  • We are indebted to her for all that she has accomplished for the Foundation and more importantly, for children diagnosed with pediatric cancer.
  • Her leadership and commitment to the Foundation has been a force multiplier and her new role capitalizes on her strengths,” said Pediatric Cancer Research Foundation Board President Steve Giusto.

WHY Brands Inc. Expands Leadership Team with Two Key Executive Hires

Retrieved on: 
Wednesday, March 20, 2024
Family, Lifestyle, Retail, Consumer, Baby, Maternity, Specialty, Mother, Growth, New product development, Strategic management, Munchkin, Shearman, Caregiver, General counsel, AI, Xero, Engineering, Massage, Shearman & Sterling, Pushpay, Corporation, Industrial design

Both executives will report to Steven B. Dunn, Founder and Chief Executive Officer of WHY.

Key Points: 
  • Both executives will report to Steven B. Dunn, Founder and Chief Executive Officer of WHY.
  • “We are excited to expand our leadership bench with the strategic appointments of Joseph and Jaime,” said Mr. Dunn.
  • “As WHY moves into more tech-focused, high value products and household goods, we are embarking on a new chapter of growth.
  • Prior to joining WHY, Mr. Berkowitz was General Counsel & Head of Corporate Strategy at Pushpay, a leading fintech company.

Ivy Fertility Hires Dr. Bryn Willson and Dr. Shelun Tsai

Retrieved on: 
Thursday, March 21, 2024
Baby, Maternity, Managed Care, Other Health, Health, Women, Other Science, Research, Hospitals, Genetics, Consumer, Science, Cedars-Sinai Medical Center, Education, Weill Cornell Medicine, SDFC, Patient, Duke University, UC, University, Weill Cornell Medical Center, MD, Pacific coast, Infertility, Gynaecology, Harvard University, University of California, Davis, Santa Clara University, Golden apple, Obstetrics, Duke, Physician, Hedera

Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.

Key Points: 
  • Ivy Fertility, a collaborative network of globally-renowned fertility clinics, is thrilled to welcome Bryn Willson, MD and Shelun Tsai, MD to its collaborative team of physicians.
  • Dr. Willson and Dr. Tsai are both board-certified in obstetrics and gynecology, and will complete their fellowships in reproductive endocrinology this spring.
  • “The entire Ivy Fertility network is committed to staying at the forefront of fertility science,” said Sandy Chuan, MD, Medical Director at San Diego Fertility Center.
  • “We are privileged that Dr. Willson and Dr. Tsai will be contributing their innovation and compassion to our network.”

Samsung Accepts Healthcare Innovator Award for Contribution to Care in Underserved Communities

Retrieved on: 
Wednesday, March 20, 2024
Software, Other Health, General Health, Radiology, Consumer, Technology, Medical Devices, Hospitals, Health Technology, Other Consumer, Baby, Maternity, Women, Health, Lunch, Patient, Health care, Transport, AI, MD, Samsung, HHM, Language, Multimedia, Medical imaging

Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award for its SonoSync technology and contributions to closing the gap in quality, accessible healthcare for underserved communities.

Key Points: 
  • Boston Imaging, the United States headquarters of Samsung’s digital radiography and ultrasound business, was awarded HHM Health’s Healthcare Innovator Award for its SonoSync technology and contributions to closing the gap in quality, accessible healthcare for underserved communities.
  • The award was accepted on March 19 at HHM Health’s annual Healing Hands Luncheon in Dallas, Texas.
  • “We’re honored to receive this award and to play a part in HHM Health’s work as they provide care to underserved communities in the Dallas area,” said Tracy Bury, Women’s Health Segment Leader for Boston Imaging.
  • Tracy Bury, Beth Carini, John Dixon, and Anthony Tardi were present at the Luncheon to accept the award on behalf of Boston Imaging.

PECA Labs Receives Expanded CE Mark for exGraft Family of Vascular Grafts, Allowing for Expandability Designed to Match Growth or Help Avoid Restenosis

Retrieved on: 
Tuesday, March 19, 2024
General Health, Consumer, Medical Devices, Hospitals, Health Technology, Children, Surgery, Baby, Maternity, Cardiology, Biotechnology, FDA, Health, Member, X-ray, Growth, Ethics, Patient, Anatomy, Risk, Restenosis, Delaware Valley, University, PECA, Surgeon, Medtech, Ernst & Young, Pediatrics, Hospital, Traction, PwC, Regulation

The exGraft is a synthetic vascular graft built on PECA Labs’ proprietary polymer processing platform that can be permanently expanded.

Key Points: 
  • The exGraft is a synthetic vascular graft built on PECA Labs’ proprietary polymer processing platform that can be permanently expanded.
  • Post-operative expansion is designed to allow for increasing graft diameter, which may enable the graft to match growth in pediatric populations or help to avoid restenosis (narrowing) in adults.
  • The exGraft’s capability to be balloon-expanded in the cath lab provides cardiac care teams greater flexibility in treating patients.
  • “This CE Mark clearance, which results in an expanded label within the exGraft family of vascular grafts, is extremely significant.